{
    "clinical_study": {
        "@rank": "129338", 
        "arm_group": [
            {
                "arm_group_label": "avanafil", 
                "arm_group_type": "Experimental", 
                "description": "100 mg"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether avanafil will affect different aspects of\n      sperm production."
        }, 
        "brief_title": "Study Evaluating the Effects of Avanafil on Semen Parameters", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Erectile Dysfunction", 
        "condition_browse": {
            "mesh_term": "Erectile Dysfunction"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Provide written informed consent\n\n          -  Able to produce semen samples without requiring therapy (PDE5 inhibitors,\n             over-the-counter (OTC) medication, and/or herbal supplements) for erectile\n             dysfunction\n\n          -  Be medically healthy (no clinically significant screening results for medical\n             history, electrocardiogram (ECG), laboratory studies, physical examination, etc.) in\n             the opinion of the investigator\n\n          -  Be willing and able to comply with all study requirements\n\n        Exclusion Criteria:\n\n          -  An International Index of Erectile Function (IIEF) erectile function domain score of\n             less than 17;\n\n          -  History of infertility, vasectomy, testicular mass, testicular trauma, testicular\n             abnormality (including size), radiation to the testis, previous pelvic surgery,\n             cryotherapy of the prostate, known sperm defect, or retrograde ejaculation, or\n             cryptorchidism;\n\n          -  Resting heart rate <45 or >90 beats per minute at screening (3 rechecks permitted);\n\n          -  Screening systolic blood pressure <90 or >140 mmHg and/or diastolic blood pressure\n             <50 or >90 mmHg (3 rechecks permitted);\n\n          -  High serum FSH (>18.0 mIU/mL), high serum LH (>18 mIU/mL), or low serum testosterone\n             (< 270 ng/dL, early morning collection) on screening;\n\n          -  AST or ALT >2.0 x ULN or other evidence of significant hepatic impairment;\n\n          -  Prostate specific antigen (PSA) level \u22654 ng/mL at screening;\n\n          -  Individuals who perform rotating shift work during the course of the study."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "220", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01768676", 
            "org_study_id": "TA-401"
        }, 
        "intervention": [
            {
                "arm_group_label": "avanafil", 
                "description": "100 mg", 
                "intervention_name": "avanafil", 
                "intervention_type": "Drug", 
                "other_name": [
                    "TA-1790", 
                    "Stendra"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "healthy male", 
        "lastchanged_date": "December 9, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Huntsville", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "LA", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Parker", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aventura", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carmel", 
                        "country": "United States", 
                        "state": "Indiana"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shreveport", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bala Cynwyd", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Knoxville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "Research Facility"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "Research Facility"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Clinical Trial of the Effect of Avanafil (STENDRA\u2122) on Spermatogenesis in Healthy Adult Males and Adult Males With Mild Erectile Dysfunction", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Percentage of subjects with a greater than or equal to 50% decrease in sperm concentration from baseline to week 26", 
            "safety_issue": "Yes", 
            "time_frame": "baseline to week 26"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01768676"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "VIVUS, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "VIVUS, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}